Monogram Biosciences Announces Fourth Quarter 2005 Financial Results Conference Call
2006年2月16日 - 8:30AM
PRニュース・ワイアー (英語)
SOUTH SAN FRANCISCO, Calif., Feb. 15 /PRNewswire-FirstCall/ --
Monogram Biosciences, Inc., (NASDAQ:MGRM) announced that it will
hold a conference call on Wednesday, February 22, 2006 at 10:00
a.m. Eastern Time to discuss fourth quarter 2005 financial results.
The call will be hosted by Mr. William D. Young, Chairman & CEO
of Monogram. To participate in the live teleconference, please call
(877) 704-5384 (or 913-312-1297 for international callers) fifteen
minutes before the conference begins. Live audio of the call will
be simultaneously broadcast over the Internet and will be available
to members of the news media, investors and the general public.
Access to live and archived audio of the conference call will be
available by following the appropriate links at
http://www.monogrambio.com/ and clicking on the Investor Relations
link. Following the live broadcast, a replay of the call will also
be available at (888) 203-1112 or (719) 457-0820 for international
callers, until March 1, 2006. The replay passcode is 6918864. The
information provided on the teleconference is only accurate at the
time of the conference call, and Monogram will take no
responsibility for providing updated information except as required
by law. About Monogram Biosciences, Inc. Monogram is advancing
individualized medicine by discovering, developing and marketing
innovative products to guide and improve treatment of serious
infectious diseases and cancer. The Company's products are designed
to help doctors optimize treatment regimens for their patients that
lead to better outcomes and reduced costs. The Company's technology
is also being used by numerous biopharmaceutical companies to
develop new and improved antiviral therapeutics and vaccines as
well as targeted cancer therapeutics. More information about the
Company and its technology can be found on its web site at
http://www.monogrambio.com/. Contacts: Alfred G. Merriweather
Jeremiah Hall Chief Financial Officer Feinstein Kean Healthcare
Tel: 650 624-4576 Tel: 415 677-2700 First Call Analyst: FCMN
Contact: brenna.sweeney@fkhealth.com DATASOURCE: Monogram
Biosciences, Inc. Contact: Alfred G. Merriweather, Chief Financial
Officer of Monogram Biosciences, +1-650-624-4576, ; or Jeremiah
Hall of Feinstein Kean Healthcare, +1-415 677-2700, Web site:
http://www.monogrambio.com/
Copyright
Monogram Technologies (NASDAQ:MGRM)
過去 株価チャート
から 6 2024 まで 7 2024
Monogram Technologies (NASDAQ:MGRM)
過去 株価チャート
から 7 2023 まで 7 2024